| 000 | 01617 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250513182603.0 | ||
| 264 | 0 | _c19990513 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0040-6376 | ||
| 024 | 7 |
_a10.1136/thx.53.9.744 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTaylor, D R | |
| 245 | 0 | 0 |
_aAsthma control during long-term treatment with regular inhaled salbutamol and salmeterol. _h[electronic resource] |
| 260 |
_bThorax _cSep 1998 |
||
| 300 |
_a744-52 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlbuterol _xadministration & dosage |
| 650 | 0 | 4 |
_aAsthma _xdrug therapy |
| 650 | 0 | 4 |
_aBronchodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aCross-Over Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLong-Term Care |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPeak Expiratory Flow Rate |
| 650 | 0 | 4 | _aSalmeterol Xinafoate |
| 700 | 1 | _aTown, G I | |
| 700 | 1 | _aHerbison, G P | |
| 700 | 1 | _aBoothman-Burrell, D | |
| 700 | 1 | _aFlannery, E M | |
| 700 | 1 | _aHancox, B | |
| 700 | 1 | _aHarré, E | |
| 700 | 1 | _aLaubscher, K | |
| 700 | 1 | _aLinscott, V | |
| 700 | 1 | _aRamsay, C M | |
| 700 | 1 | _aRichards, G | |
| 773 | 0 |
_tThorax _gvol. 53 _gno. 9 _gp. 744-52 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/thx.53.9.744 _zAvailable from publisher's website |
| 999 |
_c10277956 _d10277956 |
||